K
Kurt D. Shanebeck
Researcher at MedImmune
Publications - 17
Citations - 2215
Kurt D. Shanebeck is an academic researcher from MedImmune. The author has contributed to research in topics: Antibody & T cell. The author has an hindex of 11, co-authored 15 publications receiving 2148 citations.
Papers
More filters
Journal ArticleDOI
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
Kenneth H. Grabstein,June R. Eisenman,Kurt D. Shanebeck,Charles Rauch,Subhashini Srinivasan,Victor Fung,Courtney Beers,Jane S. Richardson,Michael A. Schoenborn,Minoo Ahdieh,Lisabeth Johnson,Mark R. Alderson,James D. Watson,Dirk M. Anderson,Judith G. Giri +14 more
TL;DR: A cytokine was identified that stimulated the proliferation of T lymphocytes, and a complementary DNA clone encoding this new T cell growth factor was isolated, indicating that IL-15 uses components of the IL-2 receptor.
Journal ArticleDOI
Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines.
Kenneth H. Grabstein,June R. Eisenman,Diane Y. Mochizuki,Kurt D. Shanebeck,Paul J. Conlon,Thomas P. Hopp,Carl J. March,Steven Gillis +7 more
TL;DR: It is concluded that BSF-1 is both a growth factor and a differentiation factor that stimulated the proliferation of several IL-2- and IL-3-dependent cell lines and suggested additional biologic properties of B SF-1 on lineages besides B lymphocytes.
Journal ArticleDOI
Induction of B cell costimulatory function by recombinant murine CD40 ligand.
Mary K. Kennedy,Kendall M. Mohler,Kurt D. Shanebeck,Peter Robert Baum,Kathleen S. Picha,Carol Otten-Evans,Charles A. Janeway,Kenneth H. Grabstein +7 more
TL;DR: It is shown that recombinant membrane‐bound murine CD40L induces B cells to express costimulatory function for the proliferation of CD4+ Tcells and suggested that CD40 L‐activated B cells express an additional costimulation activity that is not associated with LPS‐ activated B cells.
Journal ArticleDOI
Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones.
TL;DR: It is demonstrated that IL‐10 inhibits splenic antigen‐presenting cell (APC)‐dependent proliferation of Th1 clones, at least in part, via down‐regulation of APC‐derived IL‐12, and the failure of activated B cells to provide costimulation via IL‐ 12 accounts for their inability to support optimal proliferative responses of Th 1 clones.
Journal ArticleDOI
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
Michael Peter Vanbrunt,Kurt D. Shanebeck,Zachary Caldwell,Jeffrey A. Johnson,Pamela Thompson,Thomas D. Martin,Huifang Dong,Gary Li,Hengyu Xu,Francois D'Hooge,Luke Masterson,Pauline A. Bariola,Arnaud C. Tiberghien,Ebele Ezeadi,David G. Williams,John A. Hartley,Philip Wilson Howard,Kenneth H. Grabstein,Michael A. Bowen,Marcello Marelli +19 more
TL;DR: A cell-based mammalian expression system capable of site-specific integration of a non-natural amino acid containing an azide moiety provides a means for the generation of ADCs with optimized pharmacokinetic, biological, and biophysical properties.